{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T12:17:52Z","timestamp":1778156272838,"version":"3.51.4"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T00:00:00Z","timestamp":1774569600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T00:00:00Z","timestamp":1778112000000},"content-version":"vor","delay-in-days":41,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Changzhou Sci&Tech Program","award":["No. CJ20240084"],"award-info":[{"award-number":["No. CJ20240084"]}]},{"name":"Subject of Changzhou Medical Center of Nanjing Medical University","award":["CMCB202421"],"award-info":[{"award-number":["CMCB202421"]}]},{"name":"Subject of Changzhou Medical Center of Nanjing Medical University","award":["CMCC202412"],"award-info":[{"award-number":["CMCC202412"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["World J Surg Onc"],"DOI":"10.1186\/s12957-026-04312-8","type":"journal-article","created":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T14:35:49Z","timestamp":1774622149000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["MiR-381-3p inhibits Warburg effect and progression in osteosarcoma via targeting PFKFB3"],"prefix":"10.1186","volume":"24","author":[{"given":"Huiqun","family":"Jiang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jingbin","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiahao","family":"Xia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuan","family":"Tao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhongxing","family":"Wan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dong","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Weihao","family":"Duan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yiping","family":"Weng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,3,27]]},"reference":[{"issue":"8","key":"4312_CR1","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1038\/s41419-019-1795-7","volume":"10","author":"T Liu","year":"2019","unstructured":"Liu T, Ma Q, Zhang Y, Wang X, Xu K, Yan K, et al. Self-seeding circulating tumor cells promote the proliferation and metastasis of human osteosarcoma by upregulating interleukin-8. Cell Death Dis. 2019;10(8):575.","journal-title":"Cell Death Dis"},{"issue":"7","key":"4312_CR2","doi-asserted-by":"publisher","first-page":"1024","DOI":"10.1038\/s12276-022-00806-z","volume":"54","author":"Y Liu","year":"2022","unstructured":"Liu Y, Qiu G, Luo Y, Li S, Xu Y, Zhang Y, et al. Circular RNA ROCK1, a novel circRNA, suppresses osteosarcoma proliferation and migration via altering the miR-532-5p\/PTEN axis. Exp Mol Med. 2022;54(7):1024\u201337.","journal-title":"Exp Mol Med"},{"issue":"17","key":"4312_CR3","doi-asserted-by":"publisher","first-page":"7710","DOI":"10.7150\/thno.45858","volume":"10","author":"XK Hu","year":"2020","unstructured":"Hu XK, Rao SS, Tan YJ, Yin H, Luo MJ, Wang ZX, et al. Fructose-coated Angstrom silver inhibits osteosarcoma growth and metastasis via promoting ROS-dependent apoptosis through the alteration of glucose metabolism by inhibiting PDK. Theranostics. 2020;10(17):7710\u201329.","journal-title":"Theranostics"},{"issue":"1","key":"4312_CR4","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1186\/s12943-020-01196-4","volume":"19","author":"X Guo","year":"2020","unstructured":"Guo X, Zhou Q, Su D, Luo Y, Fu Z, Huang L, et al. Circular RNA circBFAR promotes the progression of pancreatic ductal adenocarcinoma via the miR-34b-5p\/MET\/Akt axis. Mol Cancer. 2020;19(1):83.","journal-title":"Mol Cancer"},{"issue":"6","key":"4312_CR5","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1136\/gut.2009.181834","volume":"59","author":"Q Zhou","year":"2010","unstructured":"Zhou Q, Souba WW, Croce CM, Verne GN. MicroRNA-29a regulates intestinal membrane permeability in patients with irritable bowel syndrome. Gut. 2010;59(6):775\u201384.","journal-title":"Gut"},{"issue":"8","key":"4312_CR6","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1186\/gm272","volume":"3","author":"MY Shah","year":"2011","unstructured":"Shah MY, Calin GA. MicroRNAs miR-221 and miR-222: a new level of regulation in aggressive breast cancer. Genome Med. 2011;3(8):56.","journal-title":"Genome Med"},{"issue":"1","key":"4312_CR7","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1186\/s12957-021-02344-w","volume":"19","author":"YZ Yu","year":"2021","unstructured":"Yu YZ, Mu Q, Ren Q, Xie LJ, Wang QT, Wang CP. miR-381-3p suppresses breast cancer progression by inhibition of epithelial-mesenchymal transition. World J Surg Oncol. 2021;19(1):230.","journal-title":"World J Surg Oncol"},{"issue":"1","key":"4312_CR8","doi-asserted-by":"publisher","first-page":"e3274","DOI":"10.1002\/jgm.3274","volume":"23","author":"XS Zhu","year":"2021","unstructured":"Zhu XS, Zhou HY, Yang F, Zhang HS, Ma KZ. miR-381-3p inhibits high glucose-induced vascular smooth muscle cell proliferation and migration by targeting HMGB1. J Gene Med. 2021;23(1):e3274.","journal-title":"J Gene Med"},{"issue":"1","key":"4312_CR9","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1186\/s40659-018-0189-0","volume":"51","author":"M Wu","year":"2018","unstructured":"Wu M, Fan B, Guo Q, Li Y, Chen R, Lv N, et al. Knockdown of SETDB1 inhibits breast cancer progression by miR-381-3p-related regulation. Biol Res. 2018;51(1):39.","journal-title":"Biol Res"},{"issue":"1","key":"4312_CR10","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1002\/jcb.27438","volume":"120","author":"A Shang","year":"2019","unstructured":"Shang A, Zhou C, Bian G, Chen W, Lu W, Wang W, et al. miR-381-3p restrains cervical cancer progression by downregulating FGF7. J Cell Biochem. 2019;120(1):778\u201389.","journal-title":"J Cell Biochem"},{"issue":"5","key":"4312_CR11","first-page":"2505","volume":"24","author":"CH Zhao","year":"2020","unstructured":"Zhao CH, Bai XF, Hu XH. Knockdown of lncRNA XIST inhibits hypoxia-induced glycolysis, migration and invasion through regulating miR-381-3p\/NEK5 axis in nasopharyngeal carcinoma. Eur Rev Med Pharmacol Sci. 2020;24(5):2505\u201317.","journal-title":"Eur Rev Med Pharmacol Sci"},{"issue":"1","key":"4312_CR12","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1515\/biol-2020-0070","volume":"15","author":"F Gu","year":"2020","unstructured":"Gu F, Zhang J, Yan L, Li D. CircHIPK3\/miR-381-3p axis modulates proliferation, migration, and glycolysis of lung cancer cells by regulating the AKT\/mTOR signaling pathway. Open life Sci. 2020;15(1):683\u201395.","journal-title":"Open life Sci"},{"key":"4312_CR13","doi-asserted-by":"publisher","first-page":"1015593","DOI":"10.1155\/2022\/1015593","volume":"2022","author":"L Li","year":"2022","unstructured":"Li L, Zhou X, Zhang W, Zhao R. Identification of Key Genes and miRNAs Affecting Osteosarcoma Based on Bioinformatics. Dis Markers. 2022;2022:1015593.","journal-title":"Dis Markers"},{"key":"4312_CR14","doi-asserted-by":"crossref","unstructured":"Sampedro-N\u00fa\u00f1ez M, Bouthelier A, Serrano-Somavilla A, Mart\u00ednez-Hern\u00e1ndez R, Adrados M, Mart\u00edn-P\u00e9rez E et al. LAT-1 and GLUT-1 Carrier Expression and Its Prognostic Value in Gastroenteropancreatic Neuroendocrine Tumors. Cancers (Basel). 2020;12(10).","DOI":"10.3390\/cancers12102968"},{"issue":"6","key":"4312_CR15","first-page":"1044","volume":"17","author":"F Zhang","year":"2016","unstructured":"Zhang F, Ren C, Lau KK, Zheng Z, Lu G, Yi Z, et al. A network medicine approach to build a comprehensive atlas for the prognosis of human cancer. Brief Bioinform. 2016;17(6):1044\u201359.","journal-title":"Brief Bioinform"},{"key":"4312_CR16","doi-asserted-by":"publisher","first-page":"156949","DOI":"10.1016\/j.phymed.2025.156949","volume":"144","author":"Q Wang","year":"2025","unstructured":"Wang Q, Yuan X, Li H, Li J, Wu Z, Zhang W, et al. Guggulsterone suppresses osteosarcoma progression by inhibiting glycolysis through MAPK signaling pathway. Phytomedicine: Int J phytotherapy phytopharmacology. 2025;144:156949.","journal-title":"Phytomedicine: Int J phytotherapy phytopharmacology"},{"issue":"1","key":"4312_CR17","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1186\/s12964-023-01321-y","volume":"22","author":"Z Mei","year":"2024","unstructured":"Mei Z, Shen Z, Pu J, Liu Q, Liu G, He X, et al. NAT10 mediated ac4C acetylation driven m(6)A modification via involvement of YTHDC1-LDHA\/PFKM regulates glycolysis and promotes osteosarcoma. Cell communication signaling: CCS. 2024;22(1):51.","journal-title":"Cell communication signaling: CCS"},{"issue":"1","key":"4312_CR18","doi-asserted-by":"publisher","first-page":"e13344","DOI":"10.1111\/cpr.13344","volume":"56","author":"F Yang","year":"2023","unstructured":"Yang F, Liu Y, Xiao J, Li B, Chen Y, Hu A, et al. Circ-CTNNB1 drives aerobic glycolysis and osteosarcoma progression via m6A modification through interacting with RBM15. Cell Prolif. 2023;56(1):e13344.","journal-title":"Cell Prolif"},{"key":"4312_CR19","doi-asserted-by":"crossref","unstructured":"Wei X, Feng J, Chen L, Zhang C, Liu Y, Zhang Y et al. METTL3-mediated m6A modification of LINC00520 confers glycolysis and chemoresistance in osteosarcoma via suppressing ubiquitination of ENO1. Cancer Lett. 2024:217194.","DOI":"10.1016\/j.canlet.2024.217194"},{"key":"4312_CR20","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.molmet.2019.01.014","volume":"23","author":"AV Orang","year":"2019","unstructured":"Orang AV, Petersen J, McKinnon RA, Michael MZ. Micromanaging aerobic respiration and glycolysis in cancer cells. Mol metabolism. 2019;23:98\u2013126.","journal-title":"Mol metabolism"},{"issue":"1","key":"4312_CR21","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1186\/s12967-024-04957-7","volume":"22","author":"W Zhou","year":"2024","unstructured":"Zhou W, Tang M, He D, Shen Y, Huang Z, Xia W, et al. Hypoxia promotes metastasis by relieving miR-598-3p-restricted glycolysis in gastric cancer. J translational Med. 2024;22(1):283.","journal-title":"J translational Med"},{"issue":"11","key":"4312_CR22","doi-asserted-by":"publisher","first-page":"3105","DOI":"10.1038\/s41418-021-00804-0","volume":"28","author":"Y Hou","year":"2021","unstructured":"Hou Y, Zhang Q, Pang W, Hou L, Liang Y, Han X, et al. YTHDC1-mediated augmentation of miR-30d in repressing pancreatic tumorigenesis via attenuation of RUNX1-induced transcriptional activation of Warburg effect. Cell Death Differ. 2021;28(11):3105\u201324.","journal-title":"Cell Death Differ"},{"issue":"3","key":"4312_CR23","doi-asserted-by":"publisher","first-page":"e36","DOI":"10.1002\/imt2.36","volume":"1","author":"W Shen","year":"2022","unstructured":"Shen W, Song Z, Zhong X, Huang M, Shen D, Gao P, et al. Sangerbox: A comprehensive, interaction-friendly clinical bioinformatics analysis platform. iMeta. 2022;1(3):e36.","journal-title":"iMeta"},{"issue":"1","key":"4312_CR24","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1515\/biol-2020-0086","volume":"15","author":"J Zhang","year":"2020","unstructured":"Zhang J, Rao D, Ma H, Kong D, Xu X, Lu H. LncRNA SNHG15 contributes to doxorubicin resistance of osteosarcoma cells through targeting the miR-381-3p\/GFRA1 axis. Open life Sci. 2020;15(1):871\u201383.","journal-title":"Open life Sci"},{"issue":"1","key":"4312_CR25","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.cmet.2015.12.006","volume":"23","author":"NN Pavlova","year":"2016","unstructured":"Pavlova NN, Thompson CB. The Emerging Hallmarks of Cancer Metabolism. Cell Metab. 2016;23(1):27\u201347.","journal-title":"Cell Metab"},{"issue":"1","key":"4312_CR26","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1038\/s41420-022-01054-w","volume":"8","author":"B Wang","year":"2022","unstructured":"Wang B, Li D, Ilnytskyy Y, Kovalchuk I, Kovalchuk O. A miR-34a-guided, tRNA(i)(Met)-derived, piR_019752-like fragment (tRiMetF31) suppresses migration and angiogenesis of breast cancer cells via targeting PFKFB3. Cell death discovery. 2022;8(1):355.","journal-title":"Cell death discovery"},{"issue":"6","key":"4312_CR27","first-page":"396","volume":"38","author":"X Gao","year":"2023","unstructured":"Gao X, Liu H, Wu Q, Wang R, Huang M, Ma Q, et al. miRNA-381-3p Functions as a Tumor Suppressor to Inhibit Gastric Cancer by Targeting Fibroblast Growth Factor Receptor-2. Cancer Biother Radiopharm. 2023;38(6):396\u2013404.","journal-title":"Cancer Biother Radiopharm"},{"issue":"4\u20135","key":"4312_CR28","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1111\/iep.12401","volume":"102","author":"Y Zhang","year":"2021","unstructured":"Zhang Y, Li K, Wang W, Han J. miR-381-3p attenuates doxorubicin resistance in human anaplastic thyroid carcinoma via targeting homeobox A9. Int J Exp Pathol. 2021;102(4\u20135):209\u201317.","journal-title":"Int J Exp Pathol"},{"issue":"5","key":"4312_CR29","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","volume":"144","author":"D Hanahan","year":"2011","unstructured":"Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell. 2011;144(5):646\u201374.","journal-title":"Cell"},{"issue":"12","key":"4312_CR30","doi-asserted-by":"publisher","first-page":"2707","DOI":"10.7150\/ijbs.38104","volume":"15","author":"A Fu","year":"2019","unstructured":"Fu A, Hou Y, Yu Z, Zhao Z, Liu Z. Healthy mitochondria inhibit the metastatic melanoma in lungs. Int J Biol Sci. 2019;15(12):2707\u201318.","journal-title":"Int J Biol Sci"},{"key":"4312_CR31","doi-asserted-by":"publisher","first-page":"e19369","DOI":"10.7717\/peerj.19369","volume":"13","author":"N Zhu","year":"2025","unstructured":"Zhu N, Hou J, Zhang Y, Yang N, Ding K, Chang C, et al. A prognostic glycolysis-related gene signature in osteosarcoma: implications for metabolic programming, immune microenvironment, and drug response. PeerJ. 2025;13:e19369.","journal-title":"PeerJ"},{"issue":"1","key":"4312_CR32","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/j.yexcr.2018.05.008","volume":"369","author":"K Ren","year":"2018","unstructured":"Ren K, Zhang J, Gu X, Wu S, Shi X, Ni Y, et al. Migration-inducing gene-7 independently predicts poor prognosis of human osteosarcoma and is associated with vasculogenic mimicry. Exp Cell Res. 2018;369(1):80\u20139.","journal-title":"Exp Cell Res"},{"key":"4312_CR33","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1016\/j.ebiom.2019.03.068","volume":"42","author":"Z Jiang","year":"2019","unstructured":"Jiang Z, Liu Z, Li M, Chen C, Wang X. Increased glycolysis correlates with elevated immune activity in tumor immune microenvironment. EBioMedicine. 2019;42:431\u201342.","journal-title":"EBioMedicine"},{"issue":"8","key":"4312_CR34","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1038\/aps.2016.47","volume":"37","author":"XS Chen","year":"2016","unstructured":"Chen XS, Li LY, Guan YD, Yang JM, Cheng Y. Anticancer strategies based on the metabolic profile of tumor cells: therapeutic targeting of the Warburg effect. Acta Pharmacol Sin. 2016;37(8):1013\u20139.","journal-title":"Acta Pharmacol Sin"},{"issue":"1","key":"4312_CR35","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1186\/s10020-025-01205-6","volume":"31","author":"W Zhang","year":"2025","unstructured":"Zhang W, Xia M, Li J, Liu G, Sun Y, Chen X, et al. Warburg effect and lactylation in cancer: mechanisms for chemoresistance. Mol Med (Cambridge Mass). 2025;31(1):146.","journal-title":"Mol Med (Cambridge Mass)"},{"issue":"1","key":"4312_CR36","doi-asserted-by":"publisher","first-page":"30","DOI":"10.7150\/ijbs.65255","volume":"18","author":"Z Li","year":"2022","unstructured":"Li Z, Geng M, Ye X, Ji Y, Li Y, Zhang X, et al. IRF7 inhibits the Warburg effect via transcriptional suppression of PKM2 in osteosarcoma. Int J Biol Sci. 2022;18(1):30\u201342.","journal-title":"Int J Biol Sci"},{"issue":"12","key":"4312_CR37","doi-asserted-by":"publisher","first-page":"4747","DOI":"10.1111\/cas.15989","volume":"114","author":"C Zheng","year":"2023","unstructured":"Zheng C, Li R, Zheng S, Fang H, Xu M, Zhong L. The knockdown of lncRNA DLGAP1-AS2 suppresses osteosarcoma progression by inhibiting aerobic glycolysis via the miR-451a\/HK2 axis. Cancer Sci. 2023;114(12):4747\u201362.","journal-title":"Cancer Sci"},{"key":"4312_CR38","doi-asserted-by":"crossref","unstructured":"Fellenberg J, Losch S, Tripel E, Lehner B, Melnik S. The Warburg Trap: A Novel Therapeutic Approach for Targeting Osteosarcoma. Cells. 2023;13(1).","DOI":"10.3390\/cells13010061"},{"key":"4312_CR39","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.canlet.2016.09.020","volume":"384","author":"J Luo","year":"2017","unstructured":"Luo J, Hong Y, Lu Y, Qiu S, Chaganty BK, Zhang L, et al. Acetyl-CoA carboxylase rewires cancer metabolism to allow cancer cells to survive inhibition of the Warburg effect by cetuximab. Cancer Lett. 2017;384:39\u201349.","journal-title":"Cancer Lett"},{"key":"4312_CR40","doi-asserted-by":"publisher","first-page":"17044","DOI":"10.1038\/sigtrans.2017.44","volume":"2","author":"L Shi","year":"2017","unstructured":"Shi L, Pan H, Liu Z, Xie J, Han W. Roles of PFKFB3 in cancer. Signal Transduct Target therapy. 2017;2:17044.","journal-title":"Signal Transduct Target therapy"},{"key":"4312_CR41","doi-asserted-by":"publisher","first-page":"748403","DOI":"10.3389\/fonc.2022.748403","volume":"12","author":"YX Jiang","year":"2022","unstructured":"Jiang YX, Siu MKY, Wang JJ, Leung THY, Chan DW, Cheung ANY, et al. PFKFB3 Regulates Chemoresistance, Metastasis and Stemness via IAP Proteins and the NF-\u03baB Signaling Pathway in Ovarian Cancer. Front Oncol. 2022;12:748403.","journal-title":"Front Oncol"},{"issue":"1","key":"4312_CR42","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1186\/s12964-022-00882-8","volume":"20","author":"J Hu","year":"2022","unstructured":"Hu J, Cao J, Jin R, Zhang B, Topatana W, Juengpanich S, et al. Inhibition of AMPK\/PFKFB3 mediated glycolysis synergizes with penfluridol to suppress gallbladder cancer growth. Cell communication signaling: CCS. 2022;20(1):105.","journal-title":"Cell communication signaling: CCS"},{"issue":"8","key":"4312_CR43","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1080\/14728222.2018.1498082","volume":"22","author":"R Bartrons","year":"2018","unstructured":"Bartrons R, Rodr\u00edguez-Garc\u00eda A, Simon-Molas H, Casta\u00f1o E, Manzano A, Navarro-Sabat\u00e9 \u00c0. The potential utility of PFKFB3 as a therapeutic target. Expert Opin Ther Targets. 2018;22(8):659\u201374.","journal-title":"Expert Opin Ther Targets"}],"container-title":["World Journal of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12957-026-04312-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12957-026-04312-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12957-026-04312-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T12:02:36Z","timestamp":1778155356000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12957-026-04312-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,27]]},"references-count":43,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4312"],"URL":"https:\/\/doi.org\/10.1186\/s12957-026-04312-8","relation":{},"ISSN":["1477-7819"],"issn-type":[{"value":"1477-7819","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,27]]},"assertion":[{"value":"30 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the research medical ethics committee of the Affiliated Hospital of the Nanjing Medical University Animal Protection and Use Committee.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"195"}}